Global Cartilage Repair Market 2023-2030

Description

List of Tables

Global Cartilage Repair Market Size, Share & Trends Analysis Report by Types of Colorectal Cancer (Cell Based and Non-Cell Based), by Application Site (Ankle, Foot, Knee, and Hip), by Application (Hyaline Cartilage and Fibrocartilage), and by End-User (Hospitals and Ambulatory Surgical Centers), Forecast Period (2023-2030)

The global cartilage repair market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). The market growth is driven by the increasing incidence of bone and joint disorders, such as osteoarthritis, as well as advancements in cartilage regeneration technology. The increasing prevalence of osteoarthritis is attributed to factors such as the expanding geriatric population and the rising impact of obesity and other related factors. According to the WHO, in 2019, about 528 million people around the globe were living with osteoarthritis, an increase of 113% since 1990. About 73% of people living with osteoarthritis are older than 55 years, and 60% are female. With a prevalence of 365 million, the knee is the most frequently affected joint, followed by the hip and the hand.

Segmental Outlook

The global cartilage repair market is segmented on the modality, application site, application, and end-user. Based on the modality, the market is sub-segmented into cell based and non-cell based. Based on the application site, the market is sub-segmented into ankle, foot, knee, and hip. Based on the application, the market is sub-segmented into hyaline cartilage and fibrocartilage. Further, based on end user, the market is sub-segmented into hospitals and ambulatory surgical centers. Among the modality, the cell based sub-segment is anticipated to hold a considerable share of the market, owing to the growing preference for autologous chondrocyte transplants as a surgical treatment for damaged articular cartilage, including chondral and osteochondral lesions.

The Knee Sub-Segment is Anticipated to Hold a Considerable Share of the Global Cartilage Repair Market

Among the application site, the Knee sub-segment is expected to hold a considerable share of the global cartilage repair market. Various factors are attributed to the knee surgery including the increasing ageing population, investments in research and development activities, the growing preference for minimally invasive procedures, rising road accidents and sports-related injuries. According to the Arthroscopy, Sports Medicine, and Rehabilitation, structural knee injuries occurred in 21% of players in this study with an overall rate of 5.42 injuries per 1,000 game exposures. Stratified by age, structural knee injury rate was greatest in players less than 20 years old (3.23/1000 GE) followed by less than 30 years old (3.11/1000 GE), 25 to 29 years (2.97/1000 GE), and 20 to 24 years (2.26/100 GE). Knee injury by minutes per game, the rate was greatest in those playing more than 30 minutes (3.86/1000 GE), followed by 20.0 to 29.9 minutes (3.03/1000 GE), and 10.0 to 19.9 minutes (1.82/1000 GE).

Regional Outlook

The global cartilage repair market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to grow over the forecast year, owing to the rising treatment rates, inflated medicine prices, advanced medical technologies, the rising disposable income coupled with improving healthcare infrastructure in emerging economies are driving the cartilage repair market in the Asia Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Cartilage Repair Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to factors including the rising incidence of osteoarthritis, favorable government initiatives and highly developed healthcare infrastructure. According to the Centers for Disease Control and Prevention, during 2019-2021, about 1 in 5 US adults (21.2%) or about 53.2 million people had doctor-diagnosed arthritis. Arthritis was more common among women (20.9%) compared to men (16.3%). Thus, the increasing incidence of osteoarthritis is expected to drive the demand for cartilage repair and regeneration products.

Market Players Outlook

The major companies serving the cartilage repair market include Zimmer Biomet Holdings, Inc., Conmed Corp., Stryker Corp., Osiris Therapeutics, Inc., Smith & Nephew Plc, Arthrex, Inc, RTI Surgical, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2023, Marrow Access Technologies signed a distribution agreement with Spartan Medical. The distribution agreement offered patients in the Department of Veterans Affairs (VA) and Department of Defense (DoD) access to the SmartShot® Marrow Access Device, a new solution for using the body's own stem cells and healing capabilities to treat orthopedic soft tissue injuries of the shoulder, hip, knee, ankle, and foot.

The Report Covers:

Market value data analysis of 2022 and forecast to 2030.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global cartilage repair market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2028009

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. B. Braun Melsungen AG
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. CONMED Corp.
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Stryker Corp.
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Zimmer Biomet Holdings, Inc.
- 3.5.1. Overview
- 3.5.2. Financial Analysis
- 3.5.3. SWOT Analysis
- 3.5.4. Recent Developments
3.6. Key Strategy Analysis

4. Market Segmentation

4.1. Global Cartilage Repair Market by Modality
- 4.1.1. Cell Based
- 4.1.2. Non-Cell Based
4.2. Global Cartilage Repair Market by Application Site
- 4.2.1. Ankle and Foot
- 4.2.2. Knee
- 4.2.3. Hip
4.3. Global Cartilage Repair Market by Application
- 4.3.1. Hyaline Cartilage
- 4.3.2. Fibrocartilage
4.4. Global Cartilage Repair Market by End-use
- 4.4.1. Hospitals
- 4.4.2. Ambulatory Surgical Centers

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Anika Therapeutics, Inc.
6.2. Arthrex, Inc
6.3. Auxein Inc.,
6.4. CartiHeal Ltd.,
6.5. Japan MDM, Inc.,
6.6. JRI Orthopaedics Ltd.,
6.7. Medacta International
6.8. Medical Device Business Services, Inc.,
6.9. MEDIPOST Co., Ltd.
6.10. Meril Life Sciences Pvt. Ltd
6.11. Osiris Therapeutics, Inc.,
6.12. RTI Surgical, Inc.,
6.13. Smith & Nephew Plc
6.14. Teijin Ltd
6.15. Vericel Corp.